KOE:048410

Hyundai Bioscience Co., Ltd. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-07 22:03 UTC

Last close

n/aKRW

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-629.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-528.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.16Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed

Growth is the furthest below its sector's middle: 0.07 against 0.50 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.19x

2.43x

2.07x

1.02x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales0.19x
Its own average over 10 years, 18.70B.
Profit2.43x
Its own average over 10 years, -9.11B.
Free cash flow2.07x
Its own average over 10 years, -9.00B.
Debt1.02x
Its own average over 10 years, 17.54B.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at 2.43 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	100.0
2017-12-31	88.6	107.5
2018-12-31	86.5	111.3
2019-12-31	83.3	114.4
2020-12-31	34.7	118.5
2021-12-31	25.6	121.9
2022-12-31	21.7	129.9
2023-12-31	26.3	131.3
2024-12-31	41.7	123.7
2025-12-31	9.7	149.2

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: KRW

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: KRW

Figures behind the shape

Growth

-22.4%

faster is higher, placed against 4,950 companies as of 2026-11-06

Five-year revenue growth rate-22.4%
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
One-year change in net income-219.3%
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed

Returns on capital

-20.0%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity-20.0%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets-16.9%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

-29.2%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin-29.2%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin-516.3%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin-629.1%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-528.5%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

4.9x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
Price to book4.9x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio154.0x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

0.16

safer is higher, placed against 3,227 companies as of 2026-11-06

Debt to equity0.16
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio2.25
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score15.65
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
KRW
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.